Healthcare -
Biotechnology - NASDAQ - US
$ 13.8
1.92 %
$ 686 M
Market Cap
-3.66
P/E
KALV - REVENUE
Revenue KALV - KalVista Pharmaceuticals, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR